Role of tumor necrosis factor-α and interleukin-10 promoter gene polymorphisms in leprosy

Journal of Infectious Diseases

Volumn 186, Issue 11, 2002, Pages 1687-1691

  Santos, Adalberto R ^a   Suffys, Philip N ^a   Vanderborght, Patricia R ^a   Moraes, Milton O ^a   Vieira, Leila M M ^a   Cabello, Pedro H ^a   Bakker, Aleida M ^c   Matos, Haroldo J ^b   Huizinga, Tom W J ^c   Ottenhoff, Tom H M ^c   Sampaio, Elizabeth P ^a   Sarno, Euzenir Nunes ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; PAUCIBACILLARY LEPROSY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN-10; LEPROSY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036890977     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/345366     Document Type: Article

References (19)

1. Moraes MO, Sarno EN, Almeida AS, et al. Cytokine mRNA expression in leprosy reaction: A possible role for interferon-γ and interleukin-12 in reactions (RR and ENL). Scand J ImmunoI 1999;50:541-9.
2. Misra N, Selvakumar M, Singh S, et al. Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy. Immunol Lett 1995;48:123-8.
3. Meyer CG, May J, Stark K. Human leukocyte antigens in tuberculosis and leprosy. Trends Microbiol 1998;6:148-54.
4. Abel L, Sanchez FO, Oberti J. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998;177:133-45.
5. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CGN, Hill AVS. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999;179:187-91.
6. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious diseases. Proc Assoc Am Physicians 1999;111:290-8.
7. Roy S, McGuire W, Mascie-Taylor CG, et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997;176:530-2.
8. Santos AR, Almeida AS, Suffys PN, et al. Tumor necrosis factor promoter polymorphism (TNF2) seemed to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int J Lepr Other Mycobact Dis 2000;68:325-7.
9. Shaw MA, Donaldson IJ, Collins A, et al. Association and linkage of leprosy phenotypes with HLA class II and tumor necrosis factor genes. Genes Immun 2001;2:196-204.
10. Hohler T, Kruger A, Schneider PM, et al. A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997;109:562-5.
11. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:110I-8.
12. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser 1982;675:1-33.
13. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor (TNF) alpha gene detectable by NcoI restriction of PCR product. Hum Mol Gen 1992;I:353.
14. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001;14:316-23.
15. Gibson AW, Edberg JC, Wu J, Westerdorp R, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-I0 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166:3915-22.
16. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-6.
17. Hoffstedt J, Eriksson P, Hellström L, Rössner S, Rydén M, Arner P. Excessive fat accumulation is associated with the TNFα -308 G/A promoter polymorphism in women but not in men. Diabetologia 2000;43:117-20.
18. Sarno EN, Santos AR, Jardim MR, et al. Pathogenesis of nerve damage in leprosy: Genetic polymorphism regulates the production of TNF alpha. Lepr Rev 2000;71:S154-8.
19. Moraes MO, Duppre NC, Suffys PN, et al. Tumor necrosis factor-α promoter polymorphism TNF2 is associated with a stronger delayed-type hyper-sensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics 2001;53:45-7.